SRZN - Surrozen, Inc./DE
28.14
-2.495 -8.866%
Share volume: 111,009
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$30.64
-2.50
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-12-2024 | 11-06-2024 | 05-09-2025 | 11-07-2025 | 03-23-2026 | |
| Cash flow financing | 0.000 | 16.086 M | -1.000 K | 76.386 M | 9.000 K | 13.781 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.065 M | |
| Cash flow | -8.753 M | 0.000 | 0.000 | 67.080 M | -9.055 M | 7.910 M | |
| Net income | -8.830 M | -25.261 M | -1.434 M | -26.970 M | -71.643 M | -183.159 M | |
| Depreciation | 392.000 K | 386.000 K | 342.000 K | 294.000 K | 61.000 K | 45.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -7.000 K | 0.000 | 0.000 | -27.000 K | -24.000 K | -59.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 7.000 K | 0.000 | 0.000 | 27.000 K | 24.000 K | 59.000 K | |
| Cash Change | -8.753 M | 10.475 M | -6.753 M | 67.080 M | -9.055 M | 7.910 M |